Swift Biosciences

45 articles about Swift Biosciences

• Swift Biosciences Meets NGS Demands by Offering 1536-Plex UDIs

  6/16/2021

  Swift Biosciences, pioneers in the development of library preparation and targeted sequencing solutions for next generation sequencing (NGS) in research applications, has announced the availability of expanded Swift Normalase Unique Dual Indexing Plates up to 1536-plex.

• Swift Biosciences launches Swift 2S™ Turbo v2 for metagenomic research

  6/7/2021

  Swift Biosciences , pioneers in the development of library preparation and targeted sequencing solutions for next generation sequencing (NGS) in research applications, has announced the release of Swift 2S™ Turbo v2 DNA Library Kits for whole genome and whole exome studies.

• Genemarkers LLC & Swift Biosciences Detect Unexpected Variant from COVID-19 S Gene Dropout Samples from Kalamazoo, MI

  2/18/2021

  Genemarkers LLC, leaders in genomic research from Kalamazoo, MI and Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing systems in Ann Arbor, MI, collaborated together to detect mutations and variants from COVID-19 samples sourced in Kalamazoo, MI.

• Swift Biosciences Accelerates its Global Expansion in China and Asia Pacific

  2/4/2021

  - A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences  announces the addition of Bruce Zhang , Director of Sales and Marketing, APAC to its global commercial team.  Bruce comes to Swift with ten years of rich experience and has led efforts in increa

• Swift Biosciences Innovates Swift 2S® Sonic DNA Library Kit for a Rapid, Cost-Effective Workflow

  10/7/2020

  Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits introduces the new Swift 2S Sonic DNA Library Kit  to the NGS Industry. After a tremendously successful debut of Swift 2S Turbo 's low-cost enzymatic fra

• Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test

  9/29/2020

  Swift Biosciences, a leader in Next-Generation Sequencing Manufacturing & Technology and BillionToOne, a precision diagnostics company today announced that Swift Bioscience will be the exclusive distributor of BillionToOne's RNA extraction-free, Emergency Use Authorization (EUA) COVID-19 Test Kit for high capacity testing of up to a million tests per day.

• Swift Biosciences Expands Coronavirus Research with ACE2 Swift Normalase® Amplicon Panel

  8/17/2020

   Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA Library Preparation Kits recently launched a new ACE2 Swift Normalase® Amplicon Panel (SNAP) to further research on the main functional receptor for viral entry of Coronavirus. With global numbers of COVID-19 cases increasing, Swift remains committed to prov

• COVID-19 Research Race Shows Importance of Speed, Precision & Efficiency in Genomic Sequencing in Fighting both New and Established Diseases

  8/3/2020

  Swift Biosciences, a leader in Next-Generation Sequencing Technology lays the groundwork for emerging research into common and rare disease as well as novel infectious disease.

• Otogenetics Ramps High Throughput NGS Clinical Sequencing Services with Swift 2S® Turbo

  7/22/2020

  Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has signed an agreement to supply its Swift 2S® Turbo DNA Library Kits to Otogenetics Corporation, a high throughput NGS clinical lab offering Prenatal Testing, Deafness Testing, Hereditary Cancer

• Swift Biosciences And Arbor Biosciences Partner On Targeted NGS Workflows For Coronavirus

  6/3/2020

  Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift's

• Swift Biosciences Enables COVID-19 Surveillance with NGS of Low Titer SARS-CoV-2 Specimens

  5/28/2020

  Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift's assay enables resea

• Swift Biosciences Launches High Throughput NGS Panel for Novel Coronavirus

  5/5/2020

  Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), announced the release of its Swift Amplicon SARS-CoV-2 Research Panel. Targeting the full viral genome in a single reaction with a rapid 2-hour workflow, Swift's assay meets research and surveillance need

• Swift Biosciences and LGC Partner on Targeted Sequencing Assays for AgBio Market

  2/24/2020

  ANN ARBOR, Mich. , Feb. 24, 2020 /PRNewswire/ -- Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), today announced a partnership agreement with LGC, Biosearch Technologies, a global leader in specialty genomic analysis tools to leverage Swift's targeted sequencing technology into LGC Biosearch T

• Helix Selects Swift Biosciences to Power Exome+™ Assay with Swift 2S™ Turbo DNA Library System

  2/4/2020

  Swift Biosciences, Inc ("Swift") and Helix OpCo, LLC ("Helix") today announced a Partnership Agreement to leverage Swift's 2S™ Turbo DNA library preparation for Helix's Exome+™ assay.

• Opentrons Labworks and Swift Bioscience Launch "Plug-Play" NGS Library Preparation Automation Workstation

  1/27/2020

  Opentrons Labworks, Inc. (“Opentrons”) and Swift Biosciences, Inc. (“Swift”) announce the launch of the most affordable fully-automated workstation for next-generation sequencing (NGS) library preparation ever put on the market.

• Swift Biosciences and Opentrons Partner to Provide a Turnkey Automated NGS Library Preparation Workflow

  1/27/2020

  Swift Biosciences, Inc ("Swift") and Opentrons Labworks, Inc. ("Opentrons") today at the SLAS2020 conference announce their partnership to leverage Swift's efficient NGS library preparation kits on Opentrons' open-source automation platform.

• Swift Biosciences Partners with MGI for High Throughput Genomic Sequencing

  1/14/2020

  Swift Biosciences, Inc. ("Swift"), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift's DNA and RNA library preparation products in Europe and Asia Pacific markets.

• Swift Biosciences Launches Normalase™, Radically Streamlining and Improving NGS Library Normalization

  11/28/2018

   Swift Biosciences today announced availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation

• Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident, Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing

  8/28/2018

  Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA).

• Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO

  5/23/2018

  Swift Biosciences, today named industry veteran Nathan Wood as its new CEO.